ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model

Published in Blood, 2019

C.-L. Chiang, S. Goswami, F. W. Frissora, Z. Xie, P. Yan, R. A. Bundschuh, L. A. Walker, X. Huang, R. Mani, X. Mo, S. Baskar, C. Rader, M. A. Phelps, G. Marcucci, J. C. Byrd, L. Lee, and N. Muthusamy. ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in CLL mouse model. Blood 134 (5) 432-444 (2019). https://doi.org/10.1182/blood.2018882290